Race differences in the prevalence of the factor V Leiden mutation in Kuwaiti nationals

Molecular Biology Reports

Volumn 38, Issue 6, 2011, Pages 3623-3628

  Dashti, Ali A ^a   Jadaon, Mehrez M ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

Factor V Leiden; Kuwaitis; Origin; Real time PCR

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DNA EXTRACTION; ETHNICITY; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GEOGRAPHIC DISTRIBUTION; GEOGRAPHIC ORIGIN; HUMAN; HUMAN CELL; HUMAN TISSUE; KUWAIT; MALE; MUTATIONAL ANALYSIS; NORMAL HUMAN; POPULATION RISK; PREVALENCE; RACE DIFFERENCE;

ADOLESCENT; ADULT; AGED; CONTINENTAL POPULATION GROUPS; FACTOR V; FEMALE; GEOGRAPHY; HUMANS; KUWAIT; MALE; MIDDLE AGED; MUTATION; PREVALENCE;

EID: 80052468398     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-010-0474-7     Document Type: Article

References (46)

1. Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde HD, van der Velden PA, Reitsma PH (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369:64-67. (Pubitemid 24144355)
2. Dahlbäck B, Carlsson M, Svensson PJ (1993) Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: Prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 90:1004-1008. (Pubitemid 23053939)
3. Ridker PM, Miletich JP, Hennekens CH, Buring JE (1997) Ethnic distribution of Factor V Leiden in 4047 men and women. Implications for venous thrmoboembolism screening. JAMA 277:1305-1307. (Pubitemid 27194355)
4. Faioni EM, Razzari C, Martinelli I, Panzeri D, Franchi F, Mannucci PM (1997) Resistance to activated protein C in unselected patients with arterial and venous thrombosis. Am J Hematol 55:59-64. (Pubitemid 27305705)
5. Rees DC, Cox M, Clegg JB (1995) World distribution of factor V Leiden. Lancet 346:1133-1134.
6. Cox MJ, Rees DC, Martinson JJ, Clegg JB (1996) Evidence of a single origin of factor V Leiden. Br J Haematol 92:1022-1025. (Pubitemid 26111173)
7. Simioni P, Prandoni P, Lensing AW, Scudeller A, Sardella C, Prims MH, Villatta S, Dazzi F, Girolami A (1997) The risk of recurrent venous thromboembolism in patients with an Arg506 → G mutation in the gene for factor V (factor V Leiden). N Engl J Med 336:399-403. (Pubitemid 27081902)
8. Dahlbäck B (1997) Resistance to activated protein C caused by the factor V R506Q mutation is a common risk factor for venous thrombosis. Thromb Haemost 78:483-488. (Pubitemid 27289289)
9. Lillicrap D (1999) Molecular diagnosis of inherited bleeding disorders and thrombophilia. Semin Hematol 36:340-351. (Pubitemid 29489660)
10. Zivelin A, Griffin JH, Xu X, Pabinger I, Samama M, Conard J, Brenner B, Eldor A, Seligsohn U (1997) A single genetic origin for a common Caucasian risk factor for venous thrombosis. Blood 89:397-402. (Pubitemid 27051673)
11. Zama T, Murata M, Ono F, Watanabe K, Watanabe R, Moriki T, Yokoyama K, Tokuhira M, Ikeda Y (1996) Low prevalence of activated protein C resistance and coagulation factor V Arg506 to Gln mutation among Japanese patients with various forms of thrombosis, and normal individuals. Int J Hematol 65:71-78. (Pubitemid 26403191)
12. Dahlbäck B (1995) Resistance to activated protein C, the Arg506 to Gln mutation in the factor V gene, and venous thrombosis. Functional tests and DNA-based assays. Pros and Cons. Thromb Haemost 73:739-742.
13. Kearon C (2001) Epidemiology of venous thromboembolism. Semin Vasc Med 1:7-26.
14. Johnson TM, El-Defrawy S, Hodge WG, Leonard BC, Kertes PJ, Taylor SAM, Lillicrap DP (2001) Prevalence of factor V Leiden and activated protein C resistance in central retinal vein occlusion. Retina 21:161-166. (Pubitemid 32298774)
15. De Maat MPM, Kluft C, Jespersen J, Gram J (1996) World distribution of factor V Leiden mutation. Lancet 347:58.
16. Dzimiri N, Meyer B (1996) World distribution of factor V Leiden. Lancet 347:481-482.
17. Arruda VR, Annichino-Bizzacchi JM, Costa FF, Reitsma PH (1995) Factor V Leiden (FVQ 506) is common in a Brazilian population. Am J Hematol 49:242-243.
18. Rosen E, Renbaum P, Heyd J, Levy-Lahad E (1999) High frequency of factor V Leiden in a population of Israeli Arabs. Thromb Haemost 82:1768.
19. Lee DH, Henderson PA, Blajchman MA (1996) Prevalence of factor V Leiden in a Canadian blood donor population. CMAJ 155:285-289. (Pubitemid 26268000)
20. Bennett JA, Palmer LJ, Musk AW, Erber WN (2001) Prevalence of factor V Leiden and prothrombin 20210A mutations in indigenous Australians. Thromb Haemost 86:1592-1593. (Pubitemid 34007544)
21. Pepe G, Rickards O, Vanegas OC, Brunelli T, Gori AM, Giusti B, Attanasio M, Prisco D, Gensini GF, Abbate R (1997) Prevalence of factor V Leiden mutation in non-European populations. Thromb Haemost 77:329-331. (Pubitemid 27084925)
22. Ho CH, Chau WK, Hsu HC, Gau JP, Chih CM (1999) Prevalence of factor V Leiden in the Chinese population. Zhonghua Yi Xue Za Zhi 62:875-878.
23. Jadaon MM, Dashti AA, Lewis HL (2010) High prevalence of activated protein C resistance and Factor V Leiden mutation in Arab population and patients with venous thrombosis in Kuwait. Diag Mol Pathol 19:180-183.
24. Almawi WY, Tamim H, Kreidy R, Timson G, Rahal E, Nabulsi M, Finan RR, Irani-Hakime N (2005) A case control study on the contribution of factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations to the genetic susceptibility of deep venous thrombosis. J Thromb Thrombolysis 19:189-196. (Pubitemid 41149481)
25. Eid SS, Shubeilat T (2005) Prevalence of Factor V Leiden, prothrombin G20210A, and MTHFR G677A among 594 thrombotic Jordanian patients. Blood Coagul Fibrinolysis 16:417-421. (Pubitemid 41215735)
26. Irani-Hakime N, Tamim H, Elias G, Finan RR, Daccache JL, Almawi WY (2000) High prevalence of factor V mutation (Leiden) in the Eastern Mediterranean. Clin Chem 46:134-136. (Pubitemid 30090977)
27. Taher A, Khalil I, Shamseddine A, El-Ahdab F, Bazarbachi A (2001) High prevalence of Factor V Leiden mutation among healthy individuals and patients with deep venous thrombosis in Lebanon: is the eastern Mediterranean region the area of origin of this mutation? Thromb Haemost 86:723-724. (Pubitemid 32743300)
28. Tamim H, Finan RR, Almawi WY (2002) Prevalence of two thrombophilia predisposing mutations: factor V G1691A (R506Q; Leiden) and prothrombin G20210A, among healthy Lebanese. Thromb Haemost 88:691-692. (Pubitemid 35174019)
29. Eid SS, Rihani G (2004) Prevalence of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations in 200 healthy Jordanians. Clin Lab Sci 17:200-202.
30. Awidi A, Shannak M, Bseiso A, Kailani MAM, Kailani MA, Omar N, Anshasi B, Sakarneh N (1999) High prevalence of Factor V Leiden in healthy Jordanian Arabs. Thromb Haemost 41:582-584. (Pubitemid 29178945)
31. Almawi WY, Keleshian SH, Borgi L, Fawaz NA, Abboud N, Mtiraoui N, Mahjoub T (2005) Varied prevalence of factor V G1691A (Leiden) and prothrombin G20210A single nucleotide polymorphisms among Arabs. J Thromb Thrombolysis 20:163-168. (Pubitemid 41662502)
32. Dashti AA, Jadaon MM, Lewis HL (2010) Factor V Leiden mutation in Arabs in Kuwait by real-time PCR: different values for different Arabs. J Hum Genet 19:180-183.
33. Pathare A, Al Kindi S, Al Haddabi H, Dennison D, Bayoumi R, Muralitharan S (2006) Hereditary thrombophilia in ethnic Omani patients. Am J Hematol 81:101-106. (Pubitemid 43208597)
34. Al-Jaouni SK (2003) Primary thrombophilia in Saudi Arabia. Saudi Med J 24:614-616. (Pubitemid 36833552)
35. Saour JN, Shoukri MM, Mammo LA (2009) The Saudi thrombosis and familial thrombophilia registry. Design, rational, and preliminary results. Saudi Med J 30:1286-1290.
36. New World Encyclopedia contributors (2008) Kuwait. New World Encyclopedia. http://www.newworldencyclopedia.org/entry/Kuwait?oldid=734001. Accessed 2 November 2010.
37. Heather Lowe (2010) Kuwait. Advameg, Inc. http://www.everyculture.com/Ja- Ma/Kuwait.html. Accessed 2 November 2010.
38. Pawar AR, Shetty S, Ghosh K, Mohanty D (2001) How old is Factor V Leiden mutation? Thromb Haemost 86:1591-1592. (Pubitemid 34007543)
39. Zeinali S, Duca F, Zarbakhsh B, Tagliabue L, Mannucci PM (2000) Thrombophilic mutations in Iran. Thromb Haemost 83:351-352. (Pubitemid 30093247)
40. Mozafari H, Rahimi Z, Heidarpour A, Fallahi M, Muniz A (2009) The prevalence of factor V Leiden, prothrombin G20210A and methylenetetrahydrofolate reductase polymorphism C677T among G6PD deficient individuals from Western Iran. Mol Biol Rep 36:2361-2364.
41. Irdem A, Devecioglu C, Batun S, Soker M, Sucakli IA (2005) Prevalence of factor V Leiden and prothrombin G20210A gene mutation. Saudi Med J 26:580-583. (Pubitemid 40711442)
42. Gurgey A, Mesci L (1997) The prevalence of factor V Leiden (1691G → A) mutation in Turkey. Turk J Pediatr 39:313-315. (Pubitemid 127562936)
43. Angelopoulou K, Nicolaides A, Constantinou Deltas C (2000) Prevalence of genetic mutations that predispose to thrombophilia in a Greek Cypriot population. Clin Appl Thromb Hemost 6:104-107. (Pubitemid 30230634)
44. Zö ller B, Hillarp A, Dahlbäck B (1997) Activated protein C resistance caused by a common factor V mutation has a single origin. Thromb Res 85:237-243. (Pubitemid 27145460)
45. Lucotte G, Mercier G (2001) Population genetics of factor V Leiden in Europe. Blood Cells Mol Dis 27:362-367. (Pubitemid 32547831)
46. Bauduer F, Lacombe D (2005) Factor V Leiden, prothrombin 20210A, methylenetetrahydrofolate reductase 677T, and population genetics. Mol Genet Metab 86:91-99. (Pubitemid 41412164)